These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22636319)
21. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. Giltiay NV; Chappell CP; Sun X; Kolhatkar N; Teal TH; Wiedeman AE; Kim J; Tanaka L; Buechler MB; Hamerman JA; Imanishi-Kari T; Clark EA; Elkon KB J Exp Med; 2013 Nov; 210(12):2773-89. PubMed ID: 24145511 [TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens. Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288 [TBL] [Abstract][Full Text] [Related]
23. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388 [TBL] [Abstract][Full Text] [Related]
24. Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling. Buechler MB; Teal TH; Elkon KB; Hamerman JA J Immunol; 2013 Feb; 190(3):886-91. PubMed ID: 23303674 [TBL] [Abstract][Full Text] [Related]
25. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7. Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064 [TBL] [Abstract][Full Text] [Related]
26. B cell induction of IL-13 expression in NK cells: role of CD244 and SLAM-associated protein. Gao N; Schwartzberg P; Wilder JA; Blazar BR; Yuan D J Immunol; 2006 Mar; 176(5):2758-64. PubMed ID: 16493031 [TBL] [Abstract][Full Text] [Related]
27. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses. Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171 [TBL] [Abstract][Full Text] [Related]
28. Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice. Lin Y; Ren L; Wang W; Di J; Zeng S; Saito S J Reprod Immunol; 2009 Oct; 82(1):12-23. PubMed ID: 19560213 [TBL] [Abstract][Full Text] [Related]
29. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005 [TBL] [Abstract][Full Text] [Related]
30. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection. Dhariwala MO; Olson RM; Anderson DM Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850 [No Abstract] [Full Text] [Related]
31. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists. Hamm S; Rath S; Michel S; Baumgartner R J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448 [TBL] [Abstract][Full Text] [Related]
32. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097 [TBL] [Abstract][Full Text] [Related]
33. TLR7 stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells. Edwards S; Jones C; Leishman AJ; Young BW; Matsui H; Tomizawa H; Murray CM; Biffen M J Immunol; 2013 Mar; 190(6):2585-92. PubMed ID: 23382558 [TBL] [Abstract][Full Text] [Related]
34. TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7. Wang Y; Yan S; Yang B; Wang Y; Zhou H; Lian Q; Sun B FEBS Lett; 2015 May; 589(12):1322-30. PubMed ID: 25907537 [TBL] [Abstract][Full Text] [Related]
35. Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer. Koga-Yamakawa E; Dovedi SJ; Murata M; Matsui H; Leishman AJ; Bell J; Ferguson D; Heaton SP; Oki T; Tomizawa H; Bahl A; Takaku H; Wilkinson RW; Harada H Int J Cancer; 2013 Feb; 132(3):580-90. PubMed ID: 22733292 [TBL] [Abstract][Full Text] [Related]
37. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Ju X; Zenke M; Hart DN; Clark GJ Blood; 2008 Aug; 112(4):1184-94. PubMed ID: 18535206 [TBL] [Abstract][Full Text] [Related]
38. Expression of TLR2, TLR3, TLR4, and TLR7 on pulmonary lymphocytes of Schistosoma japonicum-infected C57BL/6 mice. Chen D; Zhao Y; Feng Y; Jin C; Yang Q; Qiu H; Xie H; Xie S; Zhou Y; Huang J Innate Immun; 2019 May; 25(4):224-234. PubMed ID: 31018808 [TBL] [Abstract][Full Text] [Related]
39. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635 [TBL] [Abstract][Full Text] [Related]
40. BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation. Wu YY; Kumar R; Iida R; Bagavant H; Alarcón-Riquelme ME PLoS One; 2016; 11(5):e0156302. PubMed ID: 27228057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]